Skip to main content
. 2020 May 19;12:3579–3587. doi: 10.2147/CMAR.S243660

Figure 2.

Figure 2

Anlotinib shows apoptosis induction in KRAS mutant lung cancer cells. (A) Flow cytometry detection of apoptotic cells after Anlotinib treatment. (B) Western blot analysis of Bcl-2 and Bax level after Anlotinib treatment. *P<0.05 **P<0.01.